OUR SUCCESSFUL PROJECTS

APOTEX RESEARCH PRIVATE LIMITED

Apotex Research Private Limited., is a Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) Work stations, Work Tables, meeting rooms etc. by evaluating existing Architectural & process flow of current Lab. Cable Routings, Fire Suppression systems to meet New architectural changes and providing Design.The total estimated cost of the project is Rs. 3.00 Crores.

BAXTER PHARMACEUTICAL INDIA PVT. LTD.

Baxter Pharmaceuticals India Private Limited, BPIPL, is a Ahmedabad-based generic injectables facility. They formulate, fill and finish a broad portfolio of essential generic medicines with complementary strengths in anesthesia and analgesics, critical care and renal medicines, and anti-infectives in a variety of presentations including bags, vials and ampoules.

SYNGENE INTERNATIONAL LTD

Syngene International Ltd., is an integrated research, development, and manufacturing organization providing services from early discovery and development to commercial manufacturing for small and large molecules. Syngene intended to establish a PMA Lab & Analytical chemistry lab for analytical testing purposes at the existing S 17 facility at Biocon Park in Jigani link road, Bangalore. PMA Lab is an ISO 8 classified lab.The total estimated cost of the project is Rs. 4.50 Crores.

SAI LIFE SCIENCES LTD R&T BLOCKS

Sai Life Sciences Ltd., is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations that engage in the discovery, development,  and commercialisation of NCE small molecule programmes.The total estimated cost of the project is Rs. 248.00 Crores.The company is engaged in activities related to in-vitro, in-vivo, DMPK & Toxicology. The total estimated cost of the project is Rs. 248.00 Crores.

SAI LIFE SCIENCES LTD

Sai Life Sciences Ltd., is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations that engage in the discovery, development, and commercialisation of NCE small molecule programmes.
The company is engaged in activities related to in-vitro, in-vivo, DMPK & Toxicology.The in-vitro facilities offered are
-Fit for purpose essay development.

M/S STELIS BIOPHARMA PVT. LTD

The plant’s locational advantages regarding the infrastructural facilities like power, water, and roads are fully developed and connected to National Highways.The total estimated cost of the project is Rs. 248.00 Crores.This is well connected to National Highways and Airports for Domestic and International Market.The total estimated cost of the project is Rs. 248.00 Crores., manufacture Monoclonal Antibodies and Therapeutic Proteins.